Cargando…
Identification of serum MiRNAs as candidate biomarkers for non-small cell lung cancer diagnosis
BACKGROUND: Lung cancer is one of the most common solid tumors worldwide and the leading cause of cancer-associated death. Non-small cell lung cancer (NSCLC) is accounts for approximately 85% of all the lung cancers and lung squamous carcinoma (SCC) and adenocarcinoma (ADC) are the main subtypes of...
Autores principales: | Zhang, Xintong, Tan, Jinjing, Chen, Yan, Ma, Shang, Bai, Wanqiu, Peng, Yanjing, Shi, Guangli |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9756610/ https://www.ncbi.nlm.nih.gov/pubmed/36522766 http://dx.doi.org/10.1186/s12890-022-02267-6 |
Ejemplares similares
-
Combination of Serum miRNAs with Serum Exosomal miRNAs in Early Diagnosis for Non-Small-Cell Lung Cancer
por: Wu, Qingwei, et al.
Publicado: (2020) -
Circulating miRNAs in Serum as Biomarkers for Early Diagnosis of Non-small Cell Lung Cancer
por: Duan, Xiaotong, et al.
Publicado: (2021) -
Serum and tissue miRNAs: potential biomarkers for the diagnosis of cervical cancer
por: Farzanehpour, Mahdieh, et al.
Publicado: (2019) -
Serum-Exosome-Derived miRNAs Serve as Promising Biomarkers for HCC Diagnosis
por: Rui, Tao, et al.
Publicado: (2022) -
miRNAs as serum biomarkers for Duchenne muscular dystrophy
por: Cacchiarelli, Davide, et al.
Publicado: (2011)